 |
|
Treatment Typically Provided for Comorbid Anxiety Disorders
Lisa S. Meredith, PhD;
Cathy Donald Sherbourne, PhD;
Catherine A. Jackson, PhD;
Patti Camp, MS;
Kenneth B. Wells, MD, MPH
Arch Fam Med. 1997;6(3):231-237.
Abstract
| |
Objective
To study whether the extent and type of treatment for comorbid anxiety disorders varies for patients with depression, hypertension, diabetes, and heart disease treated by general medical clinicians.
Methods
Data are from 2189 general medical patients with and without comorbid anxiety disorders in the Medical Outcomes Study. Treatment data were based on clinician reports of counseling provided during a visit and patient reports of recent medication use.
Results
Patients with comorbid anxiety disorders were more likely to receive treatments for anxiety disorders than those without anxiety disorders. Among those with anxiety disorders, the use of psychosocial counseling and psychotropic medication was greater for patients with depression than for patients without depression who had chronic medical conditions. Minor tranquilizers were used more commonly than antidepressants, regardless of the type of comorbid condition. Among patients with anxiety disorders, those visiting medical subspecialists were more likely to use minor tranquilizers than those visiting family practitioners or internists. Patients of family physicians with chronic medical conditions (but not with depression) were less likely than similar patients of internists to use minor tranquilizers whether or not anxiety disorders were present.
Conclusions
Anxiety disorders co-occurring with another disease (medical illness or depression) increases the likelihood of counseling and the use of psychotropic medication in the general medical sector. Patients with a chronic medical illness with or without comorbid anxiety disorders visiting family physicians are less likely to use minor tranquilizers than those visiting subspecialists or internists.
Author Affiliations
From the RAND Health Program, Santa Monica, Calif (Drs Meredith, Sherbourne, Jackson, and Wells and Ms Camp), and the Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Neuropsychiatric Institute and Hospital, School of Medicine (Dr Wells).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Quality of Care for Primary Care Patients With Anxiety Disorders
Stein et al.
Am. J. Psychiatry 2004;161:2230-2237.
ABSTRACT
| FULL TEXT
Moving Treatment Research From Clinical Trials to the Real World
Roy-Byrne et al.
Focus 2004;2:410-415.
ABSTRACT
| FULL TEXT
Panic disorder: Psychopathology, medical management and dental implications
FRIEDLANDER et al.
Journal of the American Dental Association 2004;135:771-778.
ABSTRACT
| FULL TEXT
Moving Treatment Research From Clinical Trials to the Real World
Roy-Byrne et al.
Psychiatr. Serv. 2003;54:327-332.
ABSTRACT
| FULL TEXT
Cost-effectiveness and Cost Offset of a Collaborative Care Intervention for Primary Care Patients With Panic Disorder
Katon et al.
Arch Gen Psychiatry 2002;59:1098-1104.
ABSTRACT
| FULL TEXT
A Randomized Effectiveness Trial of Collaborative Care for Patients With Panic Disorder in Primary Care
Roy-Byrne et al.
Arch Gen Psychiatry 2001;58:869-876.
ABSTRACT
| FULL TEXT
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup et al.
NEJM 2001;344:1279-1285.
ABSTRACT
| FULL TEXT
Development of a Brief Diagnostic Screen for Panic Disorder in Primary Care
Stein et al.
Psychosom. Med. 1999;61:359-364.
ABSTRACT
| FULL TEXT
Competing Priorities and Comorbidities: So Much to Do and So Little Time
Schwenk
Arch Fam Med 1997;6:238-239.
ABSTRACT
|
